Cargando…

The healing dynamics of non‐healing wounds using cryo‐preserved amniotic membrane

We evaluated the effect of the application of cryo‐preserved amniotic membrane on the healing of 26 non‐healing wounds (18 patients) with varying aetiologies and baseline sizes (average of 15.4 cm(2)), which had resisted the standard of care treatment for 6 to 456 weeks (average 88.8 weeks). Based o...

Descripción completa

Detalles Bibliográficos
Autores principales: Svobodova, Alzbeta, Horvath, Vojtech, Smeringaiova, Ingrida, Cabral, Joao Victor, Zemlickova, Martina, Fiala, Radovan, Burkert, Jan, Nemetova, Denisa, Stadler, Petr, Lindner, Jaroslav, Bednar, Jan, Jirsova, Katerina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284646/
https://www.ncbi.nlm.nih.gov/pubmed/34791774
http://dx.doi.org/10.1111/iwj.13719
Descripción
Sumario:We evaluated the effect of the application of cryo‐preserved amniotic membrane on the healing of 26 non‐healing wounds (18 patients) with varying aetiologies and baseline sizes (average of 15.4 cm(2)), which had resisted the standard of care treatment for 6 to 456 weeks (average 88.8 weeks). Based on their average general responses to the application of cryo‐preserved AM, we could differentiate three wound groups. The first healed group was characterised by complete healing (100% wound closure, maximum treatment period 38 weeks) and represented 62% of treated wounds. The wound area reduction of at least 50% was reached for all wounds in this group within the first 10 weeks of treatment. Exactly 19% of the studied wounds responded partially to the treatment (partially healed group), reaching less than 25% of closure in the first 10 weeks and 90% at maximum for extended treatment period (up to 78 weeks). The remaining 19% of treated wounds did not show any reaction to the AM application (unhealed defects). The three groups have different profiles of wound area reduction, which can be used as a guideline in predicting the healing prognosis of non‐healing wounds treated with a cryo‐preserved amniotic membrane.